Sep 18, 2009 by Brian Orelli, PhDUp, Down, Up. Is This Stock a Home Run or Not?Weight loss isn't enough for Arena to gain flight.
Sep 17, 2009 by Brian Orelli, PhDSleepless in SanofiIt's nothing but sleepless nights for sanofi-aventis, and there's no drug to cure it.
Sep 17, 2009 by Brian Orelli, PhDBaucuscare: Who's Paying?You are -- indirectly, of course. But nobody said reform would be cheap.
Sep 15, 2009 by Brian Orelli, PhDWhat's $115 Million Between Friends?Elan gets squeezed a little more.
Sep 14, 2009 by Brian Orelli, PhDMore Tests for Drug for Cancer PatientsA combination doesn't work, but two companies will keep trying.
Sep 10, 2009 by Brian Orelli, PhDObamacare: Something for Everyone to HateHealth insurers saw more to love, though.
Sep 10, 2009 by Brian Orelli, PhDThe Vanishing Vaccine WarAnd it had such potential to be a bloodbath.
Sep 9, 2009 by Brian Orelli, PhDDon't Like High Drug Costs? Blame Canada.Those "South Park" guys were right all along.
Sep 9, 2009 by Brian Orelli, PhDWeight Down. Stock Price Up. Really Up.Positive phase 3 trials will do that.
Sep 4, 2009 by Brian Orelli, PhDThe Billion-Dollar Lovers' Quarrel ContinuesElan had better bring candy and flowers to patch this up.
Sep 4, 2009 by Brian Orelli, PhDTakeover Likely? Management Says No!A hostile bid that management didn't want.
Sep 2, 2009 by Brian Orelli, PhDShould You Buy This Spinoff?Cardinal Health kicks its baby out of the nest.
Sep 2, 2009 by Brian Orelli, PhDPfizer's Paying $2.3 Billion Again? Oh, Wait, Never Mind.Get past the headline, Fools.
Aug 31, 2009 by Brian Orelli, PhDWinners and Losers of a Health-Care StalemateWait, there are winners? Really?
